These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 7521425
1. [Long-term prognosis after interferon therapy in chronic hepatitis type C]. Inoue O, Yano M. Nihon Rinsho; 1994 Jul; 52(7):1828-31. PubMed ID: 7521425 [Abstract] [Full Text] [Related]
3. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C. Akahane Y, Miyazaki Y, Naitoh S, Takeda K, Tsuda F, Okamoto H, Itoh K, Miyakawa Y, Mayumi M. Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500 [Abstract] [Full Text] [Related]
8. Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study. Imazeki F, Yokosuka O, Fukai K, Saisho H. Hepatology; 2003 Aug 28; 38(2):493-502. PubMed ID: 12883494 [Abstract] [Full Text] [Related]
10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug 28; 29(4):343-50. PubMed ID: 9476189 [Abstract] [Full Text] [Related]
11. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Shindo M, Ken A, Okuno T. Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234 [Abstract] [Full Text] [Related]
12. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma? Tanaka K, Sata M, Uchimura Y, Suzuki H, Tanikawa K. Oncol Rep; 1998 May 01; 5(1):205-8. PubMed ID: 9458323 [Abstract] [Full Text] [Related]
13. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes. Hopf U, Berg T, König V, Küther S, Heuft HG, Lobeck H. J Hepatol; 1996 May 01; 24(2 Suppl):67-73. PubMed ID: 8836892 [Abstract] [Full Text] [Related]
14. Long-term effect of interferon therapy on incidence of cirrhosis and hepatocellular carcinoma in Thai patients with chronic hepatitis B. Tangkijvanich P, Thong-ngam D, Mahachai V, Kladchareon N, Suwangool P, Kullavanijaya P. Southeast Asian J Trop Med Public Health; 2001 Sep 01; 32(3):452-8. PubMed ID: 11944697 [Abstract] [Full Text] [Related]
15. [Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy]. Fujiyama S, Tanaka M. Rinsho Byori; 2000 Jan 01; 48(1):5-13. PubMed ID: 10756668 [Abstract] [Full Text] [Related]
18. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C. Ueno T, Inuzuka S, Sata M, Koh H, Tamaki S, Kin M, Sugawara H, Sakata R, Torimura T, Tanikawa K. Hepatogastroenterology; 1995 Jan 01; 42(5):522-7. PubMed ID: 8751209 [Abstract] [Full Text] [Related]
20. Detection of anti-HCV IgM antibodies in patients with chronic hepatitis C treated with interferon. Picciotto A, Icardi G, Bardellini E, Borro P, Borzone S, Pireddu M, Sinelli N, Pezzano D, Orione L, Di Giacomo C. Eur J Gastroenterol Hepatol; 1995 Jul 01; 7(7):623-5. PubMed ID: 8590156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]